Preeclampsia, defined as new-onset hypertension accompanied by proteinuria occurring at
20 weeks of gestation or later, is a leading cause of perinatal morbidity and mortality …

The differences between males and females begin shortly after birth, continue throughout
prenatal development, and eventually extend into childhood and adult life. Male embryos …

Preeclampsia (PE) is a disease that is unique to pregnancy and affects multiple systems. It
can lead to maternal and perinatal mortality. The precise etiology of PE is unclear. Patients …

Preeclampsia is a pregnancy-induced hypertensive disorder, the pathophysiology of which
includes underlying maternal cardiovascular disease, deficient spiral artery remodeling …

Background Preeclampsia is a pregnancy-specific disorder that always causes maternal
and fetal serious adverse outcome. Disturbances in maternal immune tolerance to embryo at …

The human placenta is a vital connection between maternal and fetal tissues, allowing for
the exchange of molecules and modulation of immune interactions during pregnancy …

Organ transplantation is a lifesaving option for patients with advanced diseases. Rejection is
regarded as one of the most severe risk factors post-transplantation. A molecule that …

To investigate the effect of Interleukin 17 (IL-17) on the invasive capacity of trophoblast cells
and the underlying mechanism, we collected placental tissues samples from pregnant …

Preeclampsia (PE) is a pregnancy complication beginning after 20 weeks of pregnancy that
involves high blood pressure (systolic> 140 mmHg or diastolic> 90 mmHg), with or without …

Preeclampsia is a multifactorial vascular disease unique to human pregnancy. While genetic
and antiangiogenic factors are important contributors to preeclampsia susceptibility, recent …